Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2010

01.12.2010 | Original Article

High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma

verfasst von: Richard Salzman, Lukáš Pácal, Kateřina Kaňková, Josef Tomandl, Zuzana Horáková, Eva Tóthová, Rom Kostřica

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of the study was to investigate the relationships among (a) glutathione peroxidase (GPx) and malondialdehyde (MDA); (b) oncological characteristics (i.e., TNM classification, tumor grade), and; (c) prognosis of head and neck squamous cell carcinoma.

Methods

In a prospective cohort study, we followed 88 patients for 67.4 months (median 40.3) after surgery for head and neck squamous cell carcinoma. Activity of GPx was determined by ELISA and plasma MDA concentration by liquid chromatography.

Results

Lower GPx activity was observed in the T3/4 patients than in the T1/2 group. Tumor grade was significantly correlated with both GPx (P = 0.001) and MDA (P = 0.05, both Spearman). The perioperative level of MDA was higher in patients who later recurred during the follow-up period (n = 15) than in the complete remission group (P = 0.01, Mann–Whitney). Median disease-free interval and overall survival in the group with MDA > median were 29.5 and 32.0 months, respectively, and 38.4 and 40.3 months in the patient group with MDA ≤ median (P = 0.10 and P = 0.08, respectively; Kaplan–Meier). Patients with MDA levels higher than the median had a more than twofold greater risk of recurrence than patients with MDA levels smaller than the median (31.3 vs. 15.2%, P = 0.06, logrank).

Conclusion

Our results suggest that an increased MDA level at the time of initial surgery is found in patients with a high risk of recurrence, which suggests that each patient can be categorized according to risk of recurrence based on their MDA level at the time of initial surgery.
Literatur
1.
Zurück zum Zitat Arikan S, Akcay T, Konukoglu D et al (2005) The relationship between antioxidant enzymes and bladder cancer. Neoplasma 52(4):314–317PubMed Arikan S, Akcay T, Konukoglu D et al (2005) The relationship between antioxidant enzymes and bladder cancer. Neoplasma 52(4):314–317PubMed
2.
Zurück zum Zitat Jaloszynski P, Jaruga O, Olinski R et al (2003) Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx. Free Radic Res 37(3):231–240PubMedCrossRef Jaloszynski P, Jaruga O, Olinski R et al (2003) Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx. Free Radic Res 37(3):231–240PubMedCrossRef
3.
Zurück zum Zitat Curtin JF, Donovan M, Cotter TG (2002) Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265:49–72PubMedCrossRef Curtin JF, Donovan M, Cotter TG (2002) Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265:49–72PubMedCrossRef
4.
Zurück zum Zitat Subapriya R, Kumaraguruparan R, Nagini S et al (2003) Oxidant–antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods 13:77–81 Subapriya R, Kumaraguruparan R, Nagini S et al (2003) Oxidant–antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods 13:77–81
5.
Zurück zum Zitat Sabitha KE, Shyamaladevi CS (1999) Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol 35:273–277PubMedCrossRef Sabitha KE, Shyamaladevi CS (1999) Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol 35:273–277PubMedCrossRef
6.
Zurück zum Zitat Rush JW, Sandiford S (2003) Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin Biochem 36:345–351PubMedCrossRef Rush JW, Sandiford S (2003) Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin Biochem 36:345–351PubMedCrossRef
7.
Zurück zum Zitat Ratnasinghe D, Tangrea JA, Andersen MR (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60:6381–6383PubMed Ratnasinghe D, Tangrea JA, Andersen MR (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60:6381–6383PubMed
8.
Zurück zum Zitat Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63(12):3347–3351PubMed Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63(12):3347–3351PubMed
9.
Zurück zum Zitat Moscow JA, Morrow CS, He R, Mullenbach GT et al (1992) Structure and function of the 59-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene. J Biol Chem 267:5949–5958PubMed Moscow JA, Morrow CS, He R, Mullenbach GT et al (1992) Structure and function of the 59-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene. J Biol Chem 267:5949–5958PubMed
10.
Zurück zum Zitat Forsberg L, de Faire U, Morgenstern R (2001) Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389(1):84–93PubMedCrossRef Forsberg L, de Faire U, Morgenstern R (2001) Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389(1):84–93PubMedCrossRef
11.
Zurück zum Zitat Bohn SK, Smeland S, Sakhi AK (2001) Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 18(2):240–247 Bohn SK, Smeland S, Sakhi AK (2001) Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 18(2):240–247
12.
Zurück zum Zitat Smilek P, Kostřica R, Dušek M et al (2006) Predictive parameters of the head and neck carcinomas. Otorinolaryngologie a Foniatrie 55(1):228–229 Smilek P, Kostřica R, Dušek M et al (2006) Predictive parameters of the head and neck carcinomas. Otorinolaryngologie a Foniatrie 55(1):228–229
13.
Zurück zum Zitat Khoschsorur GA, Winklhofer Roob BM, Hl Rabl et al (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 52:181–184CrossRef Khoschsorur GA, Winklhofer Roob BM, Hl Rabl et al (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 52:181–184CrossRef
14.
Zurück zum Zitat Cox DR (1972) Regression models and life tables. J R Stat Soc Ser B34(2):187–220 Cox DR (1972) Regression models and life tables. J R Stat Soc Ser B34(2):187–220
15.
Zurück zum Zitat Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526CrossRef Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526CrossRef
16.
Zurück zum Zitat Salzman R, Kaňková K, Pácal L et al (2007) Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma 54:321–325PubMed Salzman R, Kaňková K, Pácal L et al (2007) Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma 54:321–325PubMed
17.
Zurück zum Zitat Szuster-Ciesielska A, Hryciuk-Umer E, Stepulak A et al (2004) Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood. Acta Oncol 43(3):252–258PubMedCrossRef Szuster-Ciesielska A, Hryciuk-Umer E, Stepulak A et al (2004) Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood. Acta Oncol 43(3):252–258PubMedCrossRef
18.
Zurück zum Zitat Yigitbasi OG, Guney E, Haghighi N et al (2000) Oxidant and antioxidant status in larynx squamous cell carcinomas. J Exp Clin Cancer Res 19(4):447–451PubMed Yigitbasi OG, Guney E, Haghighi N et al (2000) Oxidant and antioxidant status in larynx squamous cell carcinomas. J Exp Clin Cancer Res 19(4):447–451PubMed
19.
Zurück zum Zitat Bhuvarahamurthy V, Balasubramanian N, Govindasamy S (1996) Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem 158(1):17–23PubMed Bhuvarahamurthy V, Balasubramanian N, Govindasamy S (1996) Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem 158(1):17–23PubMed
20.
Zurück zum Zitat Korotkina RN, Matskevitch GN, Devlikano AS et al (2002) Activity of glutathione metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs. Bull Exp Biol Med 133(6):606–608PubMedCrossRef Korotkina RN, Matskevitch GN, Devlikano AS et al (2002) Activity of glutathione metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs. Bull Exp Biol Med 133(6):606–608PubMedCrossRef
21.
Zurück zum Zitat Kaynar H, Meral M, Turhan H et al (2005) Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 227(2):133–139 Kaynar H, Meral M, Turhan H et al (2005) Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 227(2):133–139
22.
Zurück zum Zitat Taysi S, Uslu C, Akcay F et al (2003) Malondiadehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today 33(9):651–654PubMedCrossRef Taysi S, Uslu C, Akcay F et al (2003) Malondiadehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today 33(9):651–654PubMedCrossRef
23.
Zurück zum Zitat Karu I, Taal G, Zilmer K et al (2010) Inflammatory/oxidative stress during the first week after different types of cardiac surgery. Scand Cardiovasc J 44(2):119–124PubMedCrossRef Karu I, Taal G, Zilmer K et al (2010) Inflammatory/oxidative stress during the first week after different types of cardiac surgery. Scand Cardiovasc J 44(2):119–124PubMedCrossRef
Metadaten
Titel
High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma
verfasst von
Richard Salzman
Lukáš Pácal
Kateřina Kaňková
Josef Tomandl
Zuzana Horáková
Eva Tóthová
Rom Kostřica
Publikationsdatum
01.12.2010
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2010
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0108-z

Weitere Artikel der Ausgabe 6/2010

International Journal of Clinical Oncology 6/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.